Autres langues Echo IQ Limited

Actions

Temps Différé Australian S.E. Autres places de cotation 05:49:47 29/05/2024			Varia. 5j.	Varia. 1 janv.
0,135 ^AUD	-3,57 %		-3,57 %	-20,59 %

07/05	Echo IQ dépose une demande d'autorisation de mise sur le marché d'EchoSolv auprès de la FDA américaine ; les actions chutent de 4%.	MT
02/04	Le PDG d'Echo IQ quitte ses fonctions ; le président du conseil d'administration lui succède par intérim	MT

Echo IQ Launches Heart Failure Detection Study with AI	21/05
Echo IQ Lodges US FDA Application for EchoSolv Market Clearance; Shares Fall 4%	07/05
Echo IQ CEO Steps Down; Chairman Named Interim Successor	02/04
Careteq Appoints CEO; Shares Down 6%	21/03
Echo IQ Secures R&D Tax Rebate for Fiscal Year 2023	08/03
Echo IQ Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Echo IQ Limited Announces the Resignation of Shannon Robinson from the Role of Joint Company Secretary	01/02
Respiri Signs Deal to Integrate Echo IQ’s Cardiovascular Technology to Remote Monitoring System; Shares Fall 4%	25/01
Echo IQ Appoints CEO	16/01
Echo IQ Limited Announces CEO Changes, Effective 29 January 2024	15/01
EchoIQ Applies for Patent for Heart Failure Algorithm	15/12
Echo IQ Secures R&D Tax Rebate for Fiscal Year 2022; Shares Fall 3%	04/09/23
Echo IQ Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Echo IQ Signs Deal to Pilot Heart Disease Detection Tool; Shares Jump 7%	29/08/23
Echo IQ to Launch Six Modules for Cardiology Platform	21/08/23
Echo IQ Completes Enrollment for Clinical Decision Software Study in the US	02/08/23
Echo IQ Launches Heart Valve Abnormality Module	19/07/23
Echo IQ Secures First Deal to Supply EchoSolv Technology to Australian Hospital; Shares Rise 3%	22/06/23
Core Sound Imaging, Inc. and Echo IQ Finalize Integration Agreement for EchoSolv	14/06/23
Echo IQ Announces the Appointment of Simon Tolhurst as A Non-Executive Director	01/06/23

Aucun résultat pour cette recherche